Pediatric leukemia is a common cause of disease-related fatality in children aged 1 to 10 years. This disease is usually treated with a combination of chemotherapy, radiation therapy, and bone marrow transplantation. With advancements in cancer treatment, approximately 70-80% of pediatric cancer patients have been cured with these aggressive combination therapies. However, oral and dental infection, mucositis, and necrosis of tissues can occur during the cancer treatment, which may lead to morbidity and an inferior quality of life for pediatric patients with leukemia. Early detection and radical treatment reduce the risk of oral infection and its associated systemic complications. Moreover, dental treatment such as extraction or preventive treatment of teeth should be considered before the start of the cancer treatment. However, it is difficult to provide dental treatment to pediatric patients with leukemia in usual settings due to their uncooperative behavior and/or the presence of psychiatric disorders. Therefore, general anesthesia during dental treatment is often recommended for these patients. In this paper, we reviewed the anesthetic management and perioperative complications in pediatric patients with leukemia receiving general anesthesia.
Introduction
Pediatric cancer is a common cause of disease-related fatality in children [1] [2] [3] . The common pediatric malignancies are leukemia (30%) and central nervous system (CNS) tumors (22%) [1, 4] . Leukemia is a malignancy of the bone marrow and blood. It is mainly classified according to the duration (acute or chronic) and the type of cell affected (myeloid, lymphoid, and monocytic). Acute lymphoblastic leukemia (ALL) accounts for a large majority (75%) of the cases of pediatric leukemia [1, 4] . The incidence is greatest in the first year of life, with a second peak at 2 to 4 years of age. Nevertheless, early detection and prompt therapy may potentially reduce the mortality rate associated with these pediatric malignancies [1, [4] [5] [6] .
These diseases are usually treated with a combination of chemotherapy, radiation therapy, and in the case of leukemia bone marrow transplantation. These therapies have greatly increased the chances of survival of pediatric cancer patients. With advancements in these aggressive combination therapies, approximately 70-80% of pediatric cancer patients are now cured [4, 7, 8] . However, risk stratification at relapse is based on the time from initial diagnosis to relapse, the anatomic site of relapse, and immunophenotype. Over the last two decades, the reported relapse rates have been 15-40% [9] . Improved therapy has decreased the mortality rate in induction to 2-3%. However, some patients still have severe adverse events including infection [8] .
The most common signs and symptoms of pediatric leukemia are anemia, bleeding, fever, fatigue, and bone pain [1, [4] [5] [6] 8] . In addition, intraoral manifestations include sore throat, laryngeal pain, gingival bleeding, and oral ulceration. Based on these criteria, cancer therapy should be started after diagnosing the disease.
Hyperleukocytosis (a white blood cell count in peripheral blood > 100 × 10 3 /L) is a serious life-threatening complication of pediatric acute leukemia that can cause neurologic injury, pulmonary leukostasis, and metabolic derangements [2, 3, 10] . It might be associated with 10-25% of childhood white blood cell disorders [2, 3, 10] . Leukostasis can be triggered by red blood cell transfusion and deteriorating blood viscosity [10] . The diameter of leukemic blast cells exceeds the internal diameter of capillaries and small vessels, leading to a mechanical obstruction of vessels by leukemic cells. For elevated leukocyte counts, the high fractional volume of leukocytes results in increased blood viscosity [3] . A typical sign for hyperleukocytosis is an alteration in arterial blood gas analysis. It was reported that PaO 2 is reduced due to exaggerated leukocytic oxygen consumption in vitro study. In addition, it showed a difference between the arterial oxygen saturation calculated from arterial blood gas and obtained by ear oximetry [2] . There are few previous reports on the anesthetic management of children with hyperleukocytosis [2, 10] . Thus, anesthesia care involves a careful assessment of the risks in these patients.
Oral and dental infections might complicate the cancer treatment and lead to morbidity and an inferior quality of life for pediatric cancer patients [1, [11] [12] [13] . Early detection and radical therapy reduce the risk of oral infection and its associated systemic complications. Moreover, dental treatment such as dental extractions, restorations, or preventive treatment of teeth should be administered before the start of the therapy. However, dental treatment of pediatric patients with leukemia has been reported to be difficult in the usual settings due to their uncooperative behavior and/or the presence of mental disorders. Therefore, general anesthesia is often recommended for them.
Hence, we reviewed the anesthetic management and perioperative complications of pediatric patients with leukemia receiving general anesthesia.
The Timing of Dental Treatment
According to previous reports, oncologic general treatment for pediatric patients with leukemia is divided into four phases [4, 8, [14] [15] [16] [17] [18] : Phase 1: Remission induction. It generally lasts for 28 days and consists of administration of 3 or 4 drugs (e.g., vincristine, corticosteroid, L-asparaginase, and anthracycline in ALL; anthracycline, cytarabine, and mitoxantrone in acute myeloid leukemia (AML)), with high success rate [8, [16] [17] [18] .
Phase 2: CNS preventive therapy. CNS can act as a sanctuary site for leukemic infiltrates. Because of that, administered chemotherapeutic drugs (a similar combination with induction therapy) are not able to cross the bloodbrain barrier.
Phase 3: Consolidation or intensification. It is designed to minimize the development of drug cross-resistance through intensified treatment (e.g., methotrexate and a similar combination with induction therapy in ALL; etoposide, daunorubicin, and a similar combination with induction therapy in AML), in an attempt to kill any remaining leukemic cells.
Phase 4: Maintenance. It aims to suppress the leukemic growth through continuous administration of drugs (e.g., mercaptopurine in ALL; cytarabine, mercaptopurine, and a similar combination with induction therapy in AML). The optimal duration of this phase has not been established yet, but it usually lasts from 2.5 to 3 years.
Additionally, dental consultation should be sought right away, in order to have enough time to complete the necessary therapy needed by the patient during the cancer treatment. The timing of dental treatment under general anesthesia for pediatric patients with leukemia can be divided into 3 phases [4, 13-15]:
Phase 1: Before the initiation of cancer treatment. The dentist should consult the oncologist to determine the current condition of the patient. Nonviable teeth or those that are likely to have a poor prognosis should be removed. Dental treatment should be done at least 10-14 days before starting chemotherapy.
Phase 2: During immunosuppression period (only emergency dental treatment). The oncologist should be consulted in order to know the degree of immune suppression of the patient.
Phase 3: After the cancer treatment is completed. The dentist should consult the oncologist to determine immune competence (elective dental treatment).
Pediatric patients with leukemia often undergo aggressive chemotherapy that causes a decreased production of red blood cells, resulting in anemia, during remission induction phase. Other causes of anemia include infiltration of bone marrow by malignant cells, the effects of radiotherapy, and poor nutrition. The patient's blood cell counts decrease 5-7 days after the start of the chemotherapy cycle. Then, they remain low for approximately 14-21 days, before returning to the normal levels until the next cycle begins [4, [13] [14] [15] . When decayed teeth are detected during therapy, ideally, dental treatment, such as extraction and/or preventive treatment of teeth, should be administered 7-14 days before starting another cancer therapy; this is to allow for epithelization of the site and adequate healing. However, if it is not feasible, priority should be given to eradication of acute infectious sources like extraction of decayed teeth and replacement of faulty restorations to avoid oral tissue irritation.
Most reports concerning the dental management recommend the use of antibiotic pastille [19] . However, those have been found ineffective for preventing oral mucositis, because the biofilm protects the adhering bacteria against environmental attacks. Professional oral health care is given by dentists and dental hygienists, namely, brushing and flossing, which cleaned the teeth, the buccal mucosa, and the tongue. It is more effective than using disinfectants or antibiotics [19, 20] . In addition, the prophylactic use of chlorhexidine gluconate reduces the frequency of oral mucositis and oral pathogens [1, 7, 11, 20] .
General anesthesia could be recommended for uncooperative pediatric patients with leukemia. However, we must consider the current condition. Then, alternative techniques including sedation with or nitrous oxide-oxygen analgesia with the use of local anesthesia can be employed to treat them [7] .
Preoperative Anesthetic Assessment
When dental treatment is being done under general anesthesia, anesthesiologists must check the current hematological status (complete blood count (CBC), coagulation status, and immunosuppression status), the proposed treatment protocol (chemotherapy, radiotherapy, and transplant), and dental examination (loose teeth with panoramic radiographs) of the patient [4, 14, 15] . In addition, current allergies, medications, and complications such as cardiac and lung diseases should be confirmed [4, 8, 14] .
Almost all pediatric patients with leukemia were administered blood transfusion by experienced oncologists' judgment during the cancer treatment due to decreased hemoglobin (Hb) and hematocrit level. Concerning the timing of blood transfusion before dental treatment, they should be considered immediately by checking the vital sign (HR, BP, and SpO 2 ) as well as hematological status [4, 5, 7] .
It has been reported that minor surgeries, such as dental extraction, can be performed when the platelet count is > 40,000/mm 3 ; the normal platelet count ranges from 150,000 to 400,000/mm 3 [4, 5, 7, 14] . When dental extractions are anticipated, Hb concentrations of ≧ 5.5-8 g/dL are required for effective hemostasis and reduced risk of bacterial infection [5, 6, 11, 21] . On the other hand, red blood cell transfusions for anemia in recent years have focused not on increasing the Hb level to its normal range but on maintaining a sufficient oxygen supply [21] . In patients with chronic anemia, even if the Hb level is low, the oxygen supply to peripheral tissues can be maintained by increasing the tissue blood flow volume, cardiac output, or erythrocyte 2,3-diphosphoglycerate (2,3-DPG) level [22] . It was reported that blood transfusion should be based on any sign of organ ischemia, potential or ongoing bleeding (rate and magnitude), the patient's intravascular volume status, and the patient's risk factors for complications of inadequate oxygenation [21, 22] .
The neutrophils are the body's first line of defense. The incidence and severity of infection are dependent on the number of neutrophils a person has [4, 5, 7] . However, there are no clear guidelines for the perioperative management of neutropenia. Reports indicate that dental treatment should be deferred if the neutrophil count is < 1000/mm 3 due to the risk of infection [4, 7, 8, 11, 12, 21] . Furthermore, antibiotic coverage might be prescribed to prevent any postoperative infection when the neutrophil count is between 1000 and 2000/mm 3 . The decreased production of neutrophils is associated with radiation injury that occurs during the cancer treatment. Recently, preoperative administration of G-CSF by activating factor such as nuclear factor kappa B was useful in the surgical case of a patient with neutropenia [5, 21, 23] . That if not synergistic, effects of donor stimulation protocols using G-CSF plus corticosteroids was useful [23] .
Moreover, antibiotic administration, before and after surgery, and the primary closing of the surgical wound reduce the risk of postoperative bacterial infection. Then, antibiotic prophylaxis is indicated to prevent surgical site infections [1, 5, 7, 11, 12] . In immunocompromised patients, both the antibiotic and the opportunistic microbiota can become pathogenically harmful and cause severe infections that may reach the bloodstream and lead to the occurrence of generalized infections [19] .
The normal leukocyte count in the blood is 4500-10,000/ mm 3 . Leukocyte alterations are the consequence of an imbalance between their formation in the bone marrow and their subsequent elimination by the mononuclear phagocytic system.
Pediatric patients with hyperleukocytosis are at significant perioperative risk [2, 3, 10] . Its symptom is acute dyspnea, often accompanied by confusion or disorientation, and focal deficits due to cerebral perfusion impairment. In addition, respiratory failure, intracranial hemorrhage and/or ischemia, and coagulopathy are the typical manifestations of hyperleukocytosis [2, 10] . They are prone to perioperative respiratory risk, such as fluid imbalance, neurological impairment, acute dyspnea, and acute renal failure [2, 10, 25] . The preoperative goal is hemodilution and reduction of viscosity [25, 26] . Various risks being multifactorial can only be assessed in experienced oncologists in the care for pediatric patients with hyperleukocytosis.
Several chemotherapeutic agents used for pediatric patients with leukemic could induce neuropathic pain. The patients received a regimen based on both opioids and an anticonvulsant (gabapentin), and one-third of patients were also treated with a tricyclic antidepressant (amitriptyline) [27, 28] .
Chemotherapy-induced nausea and vomiting are prevalent and detrimental side effects of cancer treatment [7, 29, 30] . Approximately 60% of patients under chemotherapy despite receiving antiemetic medications have experienced nausea and vomiting. Recommendations for the prevention of nausea and vomiting were dexamethasone, ondansetron, and chlorpromazine [29, 30] .
Anesthetic Plan
Most pediatric cancer patients with leukemia are managed acutely by hydration with a central venous access line. Afterwards, they undergo several procedures such as bone marrow aspiration, percutaneous vascular access insertion, and lumbar puncture under sedation [22] [23] [24] . Hematological cancer patients need repeated vein puncture for intravenous access; therefore, central venous catheterization becomes the standard method of care for patients who need long-term intravenous medications. However, there were reports about accidental catheter removal due to leakage and a risk of catheter embolization [31, 32] . During dental treatment, nasotracheal intubation is the most common intubation route used. It provides unrestricted and good access to the mouth, which facilitates easier insertion of the instrument [33, 34] .
However, any excessive force may increase the risks of nasal and intraoral damage and mucosal laceration. This usually occurs due to damage to Kiesselbach's plexus, located in the anterior part of the nasal septum. Various complications resulting from the nasal passage of the nasotracheal tube have been reported, the more frequent one being epistaxis. An oversized tube, the use of excessive force, or repeated unsuccessful insertion attempts increased risks of infection and bleeding. Therefore, orotracheal intubation might be better than nasotracheal intubation in these patients. A gastric tube, a suction catheter, or softening of the tracheal tube by heating in warm water could be useful. Application of phenylephrine has also been used to prepare the nasopharyngeal passages and minimize the risk of epistaxis.
For intraoperative anesthetic care in children with hyperleukocytosis, consultation with experienced hematology and oncology specialists is required. There is the potential risk of fluid overload and respiratory obstruction [2, 3, 10] . Highdose corticosteroid therapy has been reported to be helpful. In anesthetic management, it is essential to perform routine monitoring of the peripheral capillary oxygen saturation (SpO 2 [35, 36] . Hence, we should be aware of the possible development of acute respiratory failure after procedures especially in emergency cases. Reports also showed that the incidence of adverse events in pediatric patients undergoing surgery is 3.1% with respiratory events, out of the 53% of all intraoperative events [10] . If necessary, arterial catheter is useful for hemodynamic and respiratory monitoring.
The goal of intraoperative fluid management should be to maintain normovolemia while avoiding hypervolemia to minimize edema and hemodilution [37, 38] . It seems prudent to replace blood loss initially by administration of crystalloids or colloids in a 2:1 ration of estimated blood loss. If necessary, the required transfusion volume of red blood cells can be calculated as follows: body weight (kg) × desired increment in hemoglobin (g/dL) × 5. Platelet count can be expected to rise by approximately 50,000-100,000 cells/μL after transfusion of 5-10 mL/kg of a platelet concentrate. The goals should be to maintain hemodynamic stability and tissue oxygen delivery.
Many anesthetics have been widely used for pediatric cancer patients during the induction of general anesthesia. Previous studies have demonstrated that inhalational anesthetics suppress the metastatic potential of cancer cells under normoxia [39, 40] . However, it is unclear if anesthetics can suppress the metastatic potential of cancer cells. Further studies are therefore needed to clarify the effects of anesthetics in pediatric cancer patients and the underlying mechanisms.
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